Ichiro Hanamura

5.9k citations
73 papers · 2.8k · 1 hit paper · h-index 21

Impact in

  • Hematology top 0.5%
    • Multiple Myeloma Research and Treatments
  • Oncology top 5%
    • Peptidase Inhibition and Analysis

Papers in

    • Multiple Myeloma Research and Treatments 33
    • Protein Degradation and Inhibitors 16
    • Glycosylation and Glycoproteins Research 8

Ichiro Hanamura

65 papers receiving 2.7k citations

Ichiro Hanamura's Hit Papers

The molecular classification of multiple myeloma 2006 · 783 citations
7830+6+13Years since publication250500750

Peers

Ichiro Hanamura
Comparison fields: 5 of 104
  • Hematology 1.7k
  • Oncology 915
  • Molecular Biology 2.0k
  • Genetics 279
  • Cancer Research 377
Replace Kensuke Kojima with:
Kensuke Kojima Japan
Yazan Alsayed United States
Florence Magrangeas France
Amanda L. Christie United States
Artur Słupianek United States
Keita Kirito Japan
Jake Shortt Australia
Rose Ann Padua United Kingdom
Ronald W. Stam Netherlands
Michel Jourdan France
Ichiro Hanamura relative to Kensuke Kojima Japan Kensuke Kojima's profile →
Citations per field
00.5×1.7×
Kensuke Kojima · 1×
Citations per year

Countries citing papers authored by Ichiro Hanamura

Since Specialization
Citations

This map shows the geographic impact of Ichiro Hanamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ichiro Hanamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ichiro Hanamura more than expected).

Fields of papers citing papers by Ichiro Hanamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ichiro Hanamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ichiro Hanamura. The network helps show where Ichiro Hanamura may publish in the future.

Co-authors

The 25 scholars most cited alongside Ichiro Hanamura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ichiro Hanamura Line = papers co-authored together Ichiro Hanamura links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The molecular classification of multiple myeloma
Hit paper breakdown →
2006783
2 2006338
3 2006291
4 2000151
5 2011127
6 2003103
7 2010102
8 201282
9 200171
10 202265
11 201458
12 200556
13 201451
14 202151
15 201941
16 201332
17 202128
18 200326
19 201926
20 200624

About Ichiro Hanamura

Ichiro Hanamura is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Pathology and Forensic Medicine, having authored 73 papers that have together received 2.8k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (33 papers), Protein Degradation and Inhibitors (16 papers), Peptidase Inhibition and Analysis (9 papers), Glycosylation and Glycoproteins Research (8 papers), Chronic Lymphocytic Leukemia Research (5 papers), Immune Cell Function and Interaction (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Hematology (1.7k citations), Oncology (915 citations), Molecular Biology (2.0k citations), Genetics (279 citations) and Cancer Research (377 citations). Ichiro Hanamura has collaborated with scholars based in Japan, United States and Taiwan. Frequent co-authors include Bart Barlogie, John D. Shaughnessy, Fenghuang Zhan, Yongsheng Huang, Peter Stewart, John Crowley, Frits van Rhee, Jeffrey R. Sawyer, Klaus Hollmig and Mauricio Pineda‐Roman. Their work appears in journals such as Blood, International Journal of Hematology, Cancer Science, Cell Death Discovery and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact